{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:18:17Z","timestamp":1774264697152,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To characterize the changes in fundus corresponding to 120\u00b0 field of view in chronic Vogt\u2013Koyanagi\u2013Harada disease in the quiescent phase and explore the associations with irreversible complications in the fundus using widefield swept-source optical coherence tomography angiography.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Prospective cross-sectional study. Sixty-nine patients with chronic Vogt\u2013Koyanagi\u2013Harada disease (115 eyes) and 55 healthy control subjects (110 eyes) were included and underwent widefield swept-source optical coherence tomography angiography. Univariate analyses of variations in retinal and choroidal vessel density (VD), choroidal volume, and choroidal vascularity index in patients with Vogt\u2013Koyanagi\u2013Harada with different disease durations and the control subjects were conducted. Logistic regression analysis was used to identify the associations with irreversible complications, including choroidal neovascularization, vasoproliferative tumor of the retina, and chorioretinal atrophy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The Welch analysis of variance showed lower VD of superficial retina, deep retina, choriocapillaris, and large-sized and medium-sized vessels of the choroid, and choroidal volume and choroidal vascularity index in the patients with disease duration of &gt;24 months compared with those with disease duration of \u226424 months (all <jats:italic toggle=\"yes\">P<\/jats:italic> \u2264 0.011). The regression analysis revealed that the disease duration (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.008; OR = 1.02, 95% CI, 1.005\u20131.035) and VD of large-sized and medium-sized vessels of the choroid (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001; OR = 0.707, 95% CI, 0.575\u20130.87) were significantly correlated with the irreversible complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Patients with chronic Vogt\u2013Koyanagi\u2013Harada in the quiescent phase with disease duration of &gt;24 months exhibit more severe decreased VD in each layer of the retina and choroid, reduced choroidal volume, and sparse choroidal vascularity compared with those with disease duration \u226424 months. Prolonged duration and decreased VD of large-sized and medium-sized vessels of the choroid were associated with irreversible complications in the fundus.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004259","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T01:27:37Z","timestamp":1724376457000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["VASCULAR CHANGES AND IRREVERSIBLE COMPLICATIONS IN 120\u00b0 FUNDUS USING WIDEFIELD SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN VOGT\u2013KOYANAGI\u2013HARADA DISEASE"],"prefix":"10.1097","volume":"45","author":[{"given":"Suo","family":"Guo","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Branch of National Clinical Research Center for Ocular Diseases, Chongqing, China; and"},{"name":"Department of Ophthalmology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Xia","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Branch of National Clinical Research Center for Ocular Diseases, Chongqing, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Hu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Branch of National Clinical Research Center for Ocular Diseases, Chongqing, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Branch of National Clinical Research Center for Ocular Diseases, Chongqing, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Branch of National Clinical Research Center for Ocular Diseases, Chongqing, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250807","doi-asserted-by":"crossref","first-page":"100866","DOI":"10.1016\/j.preteyeres.2020.100866","article-title":"Activation of the interleukin-23\/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis","volume":"80","author":"Zhong","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"R2-20250807","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ajo.2021.03.036","article-title":"Classification criteria for Vogt-Koyanagi-Harada disease","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R3-20250807","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/09273948.2019.1624781","article-title":"Macular abnormalities in Vogt-Koyanagi-Harada disease","volume":"27","author":"Yang","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"R4-20250807","doi-asserted-by":"crossref","first-page":"698644","DOI":"10.3389\/fmed.2021.698644","article-title":"Widefield swept-source optical coherence tomography angiography assessment of choroidal changes in Vogt-Koyanagi-Harada disease","volume":"8","author":"Qian","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R5-20250807","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1080\/09273948.2020.1751212","article-title":"Retinal microcirculation defects on OCTA correlate with active inflammation and vision in Vogt-Koyanagi-Harada disease","volume":"29","author":"Liang","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R6-20250807","doi-asserted-by":"crossref","first-page":"100828","DOI":"10.1016\/j.preteyeres.2019.100828","article-title":"Interpretation of OCT and OCTA images from a histological approach: clinical and experimental implications","volume":"77","author":"Cuenca","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"R7-20250807","doi-asserted-by":"crossref","first-page":"100951","DOI":"10.1016\/j.preteyeres.2021.100951","article-title":"Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA)","volume":"84","author":"La\u00edns","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"R8-20250807","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/IAE.0000000000003709","article-title":"Analysis of vascular changes of fundus in Behcet uveitis by widefield swept source optical coherence tomography angiography and fundus fluorescein angiography","volume":"43","author":"Guo","year":"2023","journal-title":"Retina"},{"key":"R9-20250807","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R10-20250807","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamaophthalmol.2018.2664","article-title":"Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease","volume":"136","author":"Yang","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"R11-20250807","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajo.2021.03.061","article-title":"Development of classification criteria for the uveitides","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R12-20250807","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/02713683.2017.1383444","article-title":"Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents","volume":"43","author":"Yang","year":"2018","journal-title":"Curr Eye Res"},{"key":"R13-20250807","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1097\/IAE.0000000000001095","article-title":"Predictors of treatment response of vasoproliferative retinal tumors to ruthenium-106 brachytherapy","volume":"36","author":"Brockmann","year":"2016","journal-title":"Retina"},{"key":"R14-20250807","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/bjo.84.10.1162","article-title":"Vasoproliferative tumours of the retina","volume":"84","author":"Heimann","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R15-20250807","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/sj.eye.6700311","article-title":"Vasoproliferative tumours of the retina","volume":"17","author":"Jain","year":"2003","journal-title":"Eye (Lond)."},{"key":"R16-20250807","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.autrev.2014.01.023","article-title":"Diagnosis and classification of Vogt-Koyanagi-Harada disease","volume":"13","author":"Sakata","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R17-20250807","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.ophtha.2019.06.022","article-title":"Widefield OCT-angiography and fluorescein angiography assessments of nonperfusion in diabetic retinopathy and edema treated with anti-vascular endothelial growth factor","volume":"126","author":"Couturier","year":"2019","journal-title":"Ophthalmology"},{"key":"R18-20250807","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/diagnostics10010050","article-title":"Widefield swept source OCTA in retinitis pigmentosa","volume":"10","author":"Mastropasqua","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"R19-20250807","first-page":"46","article-title":"Use of OCTA, FA, and ultra-widefield imaging in quantifying retinal ischemia: a review","volume":"7","author":"Or","year":"2018","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R20-20250807","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajo.2016.01.004","article-title":"Enhanced depth imaging optical coherence tomography in uveitis: an intravisit and interobserver reproducibility study","volume":"164","author":"Kim","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R21-20250807","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/IAE.0000000000003617","article-title":"Efficacy of combined systemic corticosteroid and early immunomodulatory therapy within three months of onset in Vogt-Koyanagi-Harada disease","volume":"42","author":"Park","year":"2022","journal-title":"Retina"},{"key":"R22-20250807","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bjophthalmol-2017-311691","article-title":"Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids","volume":"103","author":"Nakayama","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"R23-20250807","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/ph15040398","article-title":"Mechanisms, pathophysiology and current immunomodulatory\/immunosuppressive therapy of non-infectious and\/or immune-mediated choroiditis","volume":"15","author":"Papasavvas","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"R24-20250807","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/IAE.0000000000003005","article-title":"Novel three types of neovascularization elsewhere determine the differential clinical features of proliferative diabetic retinopathy","volume":"41","author":"Pan","year":"2021","journal-title":"Retina"},{"key":"R25-20250807","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:49Z","timestamp":1754524849000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004259","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}